45 results
Page 2 of 3
DEFA14A
EX-10.1
8nkh3sn4j ecg
17 May 21
Additional proxy soliciting materials
7:36am
DEFA14A
EX-2.1
r6q ka19p
17 May 21
Additional proxy soliciting materials
7:36am
8-K
EX-99.2
2p0ldc uh
5 Aug 20
Regulation FD Disclosure
7:23am
8-K
EX-99.2
ke22i
28 May 20
Regulation FD Disclosure
9:12am
PRE 14A
r1uwe
17 Apr 20
Preliminary proxy
4:46pm
8-K
EX-10.1
xvqrnf32
18 Oct 19
Departure of Directors or Certain Officers
5:27pm
8-K
EX-1.1
r36stqotjr1p7
27 Jun 18
Aerpio Pharmaceuticals Announces Proposed Public Offering of Common Stock and Uplisting to Nasdaq Capital Market
4:56pm
424B5
m966fcihk5zb3i xt7vb
26 Jun 18
Prospectus supplement for primary offering
9:30am
424B5
xcsn7x23
25 Jun 18
Prospectus supplement for primary offering
5:08pm
424B3
25wngv6u 8t0f9bqjq
25 May 18
Prospectus supplement
4:33pm
424B3
yb1z0q5q2gjapco2s
25 May 18
Prospectus supplement
4:29pm
DEF 14A
c0lk0qdtxybpof
15 May 18
Definitive proxy
12:00am